Evidence map›Paper›PMID 21768115›Full record

ArticleThe Journal of biological chemistry2011

Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells.

Davide Vigetti, Manuela Rizzi, Paola Moretto, Sara Deleonibus, Jonathan M Dreyfuss, Evgenia Karousou, Manuela Viola, Moira Clerici, Vincent C Hascall, Marco F Ramoni and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Biology and biotechnology of hyaluronan.Glycoconjugate journal · 2015
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Davide VigettiDipartimento di Scienze Biomediche Sperimentali e Cliniche, Università degli Studi dell'Insubria, via JH Dunant 5, 21100 Varese, Italy.
Manuela Rizzi
Paola Moretto
Sara Deleonibus
Jonathan M Dreyfuss
Evgenia Karousou
Manuela Viola
Moira Clerici
Vincent C Hascall
Marco F Ramoni
Giancarlo De Luca
Alberto Passi
University of Insubria · ITCenter for Human Genetics · USCleveland Clinic · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smooth muscle cells (SMCs) have a pivotal role in cardiovascular diseases and are responsible for hyaluronan (HA) deposition in thickening vessel walls. HA regulates SMC proliferation, migration, and inflammation, which accelerates neointima formation. We used the HA synthesis inhibitor 4-methylumbelliferone (4-MU) to reduce HA production in human aortic SMCs and found a significant increase of apoptotic cells. Interestingly, the exogenous addition of HA together with 4-MU reduced apoptosis. A similar anti-apoptotic effect was observed also by adding other glycosaminoglycans and glucose to 4-MU-treated cells. Furthermore, the anti-apoptotic effect of HA was mediated by Toll-like receptor 4, CD44, and PI3K but not by ERK1/2.

Indexed as

ApoptosisAortaCell MovementCell ProliferationGlucoseGlycoproteinsGlycosaminoglycansHumansHyaluronan ReceptorsHyaluronic AcidHymecromoneInflammationMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Myocytes, Smooth MuscleOligonucleotide Array Sequence AnalysisGlucoseGlycoproteinsGlycosaminoglycansHyaluronan ReceptorsHyaluronic AcidHymecromoneMAPK1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Phosphatidylinositol 3-KinasesToll-Like Receptor 4

Identifiers

PMID21768115
PMCPMC3186361
OpenAlexW2011136203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.